Reply to Kalil et al., “Is Daptomycin plus Ceftaroline Associated with Better Clinical Outcomes than Standard of Care Monotherapy for Staphylococcus aureus Bacteremia?”
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.